Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis
Clinical trial NCT02782312 · COMPLETED
Trial details
- NCT number
- NCT02782312
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2012-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.